1AI algorae pharmaceuticals limited

INHERENT PROBLEMS with pd trials using brain surgery, page-7

  1. 8,681 Posts.
    lightbulb Created with Sketch. 867
    This is not a comment on the worth of the treatment, but it is a comment on the worthlessness of statistics in such small samples.

    Heaven knows what there is for the statisticians to look at further, as we have been told they will. It's like getting a radiologist to look again (and again, and again) at a hopelessly fuzzy X-ray.

    The lack of truly objective tests relating to improvement, such as cytological assays on brain cells, just compounds the statistical problem.

    It is difficult to see where the company goes from here, given that it confronts established rules for testing in medical and drug assessments.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.5¢
Change
0.000(0.00%)
Mkt cap ! $8.436M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $3.804K 760.7K

Buyers (Bids)

No. Vol. Price($)
7 4331823 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 3229885 5
View Market Depth
Last trade - 14.16pm 01/07/2025 (20 minute delay) ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.